Autosomal-dominant, Dutch-type cerebral amyloid angiopathy (D-CAA) offers a unique opportunity to develop biomarkers for pre-symptomatic cerebral amyloid angiopathy (CAA). We hypothesized that neuroimaging measures of white matter injury would be present and progressive in D-CAA prior to hemorrhagic lesions or symptomatic hemorrhage. In a longitudinal cohort of D-CAA carriers and non-carriers, we observed divergence of white matter injury measures between D-CAA carriers and non-carriers prior to the appearance of cerebral microbleeds and >14 years before the average age of first symptomatic hemorrhage. These results indicate that white matter disruption measures may be valuable cross-sectional and longitudinal biomarkers of D-CAA progression. ANN NEUROL 2022;92:358–363.

Original languageEnglish
Pages (from-to)358-363
Number of pages6
JournalAnnals of neurology
Issue number3
StatePublished - Sep 2022


Dive into the research topics of 'Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy'. Together they form a unique fingerprint.

Cite this